Development of a Mortality Prediction Model in Hospitalised SARS-CoV-2 Positive Patients Based on Routine Kidney Biomarkers
- Supplementary File 1:
ZIP-Document (ZIP, 207 KiB)
Boss, A.N.; Banerjee, A.; Mamalakis, M.; Ray, S.; Swift, A.J.; Wilkie, C.; Fanstone, J.W.; Vorselaars, B.; Cole, J.; Weeks, S.; Mackenzie, L.S. Development of a Mortality Prediction Model in Hospitalised SARS-CoV-2 Positive Patients Based on Routine Kidney Biomarkers. Int. J. Mol. Sci. 2022, 23, 7260. https://doi.org/10.3390/ijms23137260
Boss AN, Banerjee A, Mamalakis M, Ray S, Swift AJ, Wilkie C, Fanstone JW, Vorselaars B, Cole J, Weeks S, Mackenzie LS. Development of a Mortality Prediction Model in Hospitalised SARS-CoV-2 Positive Patients Based on Routine Kidney Biomarkers. International Journal of Molecular Sciences. 2022; 23(13):7260. https://doi.org/10.3390/ijms23137260
Chicago/Turabian StyleBoss, Anna N., Abhirup Banerjee, Michail Mamalakis, Surajit Ray, Andrew J. Swift, Craig Wilkie, Joseph W. Fanstone, Bart Vorselaars, Joby Cole, Simonne Weeks, and Louise S. Mackenzie. 2022. "Development of a Mortality Prediction Model in Hospitalised SARS-CoV-2 Positive Patients Based on Routine Kidney Biomarkers" International Journal of Molecular Sciences 23, no. 13: 7260. https://doi.org/10.3390/ijms23137260